Contribute Try STAT+ Today

Some of the patients had suffered heart attacks or were in septic shock; others had cancer, pneumonia, or a whole host of other conditions. From 2001 to 2012, more than 46,000 of them passed through the intensive care units at Beth Israel Deaconess Medical Center, a Boston hospital affiliated with Harvard. Their vital signs were monitored and recorded, as were their lab test results, their doctors’ notes, and reams of other data.

Today, these patients’ de-identified medical records have become a crucial cog with outsized influence in a burgeoning field of artificial intelligence research that’s trying to answer some of the toughest questions in medicine and health care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.